DGAP-News: Alphaform AG / Key word(s): Preliminary Results
Alphaform AG: Preliminary figures 2014 - Alphaform targets
double-digit revenue growth in 2015
26.02.2015 / 17:19
---------------------------------------------------------------------
Press release
Preliminary figures 2014 - Alphaform targets double-digit revenue growth in
2015
- Preliminary figures 2014: revenue increases to Euro 29 million,
consolidated net result improves to Euro -3.2 million
- Alphaform Excellence programme now in effect at all locations
Feldkirchen, 26. February 2015. According to preliminary calculations,
Alphaform AG, Europe's leading 3D printing service provider, increased its
revenue by 11.6 percent to Euro 29 million in 2014. The growth was
primarily based on positive performance in the two business segments
Additive Manufacturing Metal and Rapid Tooling and Precision Casting at the
Eschenlohe and Stade sites. As planned, the Alphaform Excellence programme
launched in early 2014 took full effect here. Alphaform is ensuring its
success in the third business segment, Additive Manufacturing Plastic at
the Feldkirchen site, with an 11-point plan issued in October 2014. The
remaining process and structural defects impeded the attainment of the Euro
30 million mark originally intended for 2014.
As expected, the implementation of the 11-point plan necessitated
additional expenses in the fourth quarter of 2014; the costs for external
consultants alone totalled approximately Euro 1 million in the last
financial year. After winning the biggest order in the company's history
amounting to Euro 10 million at the end of 2014, there were also already
considerable expenses for production preparations. According to preliminary
calculations, EBITDA subsequently reached Euro -1.4 million in 2014, but
this was significantly higher than the previous year's figure of Euro -3.5
million. The consolidated net result also improved to Euro -3.2 million
according to preliminary calculations after Euro -6.2 million in the
previous year. The difficult economic situation in the Formula 1 industry,
which had been an important customer in prototyping, particularly in the
early years, prevented a further reduction of the loss. In the fourth
quarter of 2014, Alphaform wrote off receivables against two racing teams
of Euro 0.2 million.
Conclusion of the Alphaform Excellence programme in 2015
With the Excellence programme, Alphaform optimised structures and processes
and strengthened sales and the corporate culture in the last financial
year, thus laying the necessary foundations for the transition from a
manufacturing and prototyping operation to industrial production. In the
course of 2015, Alphaform will conclude this programme and the associated
11-point plan.
For 2015 as a whole, Alphaform then expects double-digit revenue growth.
Over the course of the year, the company is also likely to exceed the
break-even point in terms of operating cash flow. "2014 was heavily
influenced by extensive restructuring," explains Alphaform CEO Dr
Hanns-Dieter Aberle, "now the focus is quite clearly on a consistent
implementation of our growth strategy." The company may have to continue
shouldering considerable expenses for the expansion, but it benefited from
tailwind in the 3D market, a robust business model and a high degree of
production industrialisation compared to the rest of the sector.
About Alphaform
Founded in 1996 and headquartered in Feldkirchen near Munich, Alphaform AG
is a leading European handler for the renovation of industrial development
and production with innovative 3D printing and rapid technologies. As a
service provider, Alphaform guides its clients from product development
through to product manufacture; it assists them in introducing and
utilising innovations and delivers expertise, engineering knowledge,
prototypes, individual parts, small-scale series, series and project
management.
Among others, Alphaform today serves the premium manufacturers of the
automotive industry, mechanical, plant and automotive engineering, the
aerospace industry, tool making and medical technology. Its particular
areas of expertise include complex assembly, lightweight construction and
orthopaedic implants and instruments. It has subsidiaries in Germany,
Finland, Sweden and the UK. Alphaform's shares are listed in the Prime
Standard segment of the Frankfurt stock exchange (code: ATF; securities
code number (WKN): 548 795).
Contact:
Dr. Hanns-Dieter Aberle, CEO Thomas Kresser, CFO
ALPHAFORM AG ALPHAFORM AG
KapellenstraÃe 10 KapellenstraÃe 10
85622 Feldkirchen 85622 Feldkirchen
Tel.: +49 89 905002 35 Tel.: +49 89 905002 35
Fax: +49 89 905002 1035 Fax: +49 89 905002 1035
e-mail: hdaberle@alphaform.de e-mail: tkresser@alphaform.de
Internet: www.alphaform.de Internet: www.alphaform.de
Disclaimer
This press release/ad-hoc disclosure is not an offer document and does not
constitute an offer of shares of Alphaform AG ("Company") nor an invitation
to an offer to buy or subscribe for shares or securities of the Company but
is provided for information only. This press release/ad-hoc disclosure may
contain forward-looking statements that are subject to risks and
uncertainties, including those pertaining to the anticipated benefits to be
realized from the proposals described herein. Forward-looking statements
may include, in particular, statements about future events, future
financial performance, plans, strategies, expectations, prospects,
competitive environment, regulation and supply and demand. The Company has
based these forward-looking statements on its views and assumptions with
respect to future events and financial performance. Actual financial
performance could differ materially from that projected in the
forward-looking statements due to the inherent uncertainty of estimates,
forecasts and projections, and financial performance may be better or worse
than anticipated. Given these uncertainties, persons should not put undue
reliance on any forward-looking statements. The information contained in
this presentation is subject to change without notice and the Company does
not undertake any duty to update the forward-looking statements, and the
estimates and assumptions associated with them, except to the extent
required by applicable laws and regulations.
Important notice to persons in the United States of America
All information in this press release/ad-hoc disclosure is being made
available in the United States of America only to persons believed by the
Company to be capable of understanding and evaluating the risks of a
transaction. No shares or other securities of the Company have been
registered or otherwise qualify for a public sale or resale under federal
or state laws in the United States of America. Each recipient of
information doing business in or organized under any federal or state laws
in the United States of America or in areas subject to its jurisdiction
represents that it is an "accredited investor" as defined by Rule 501 or
Regulation D under the Securities Act of 1993 ("the Act") and acknowledges
that none of the shares in the Company will be registered under the Act and
cannot be resold in the absence of such registration or the availability of
an exemption there from. The shares in the Company have not been approved
or disapproved by the United States Securities and Exchange Commission, any
state securities commission or other regulatory authority, nor have any of
these authorities passed judgment upon or endorsed the merits of an
investment in the shares of the Company or the accuracy or adequacy of this
presentation. Any representation to the contrary is a criminal offence.
Important notice to persons in the United Kingdom
All information in this press release/ad-hoc disclosure is being made
available to the recipients on the basis that they are persons covered by
Article 11(3) of the Financial Services Act 1986 (Investment
Advertisements) (Exemptions) Order 1996. By accepting this document the
recipient warrants and represents that he or it is such a person.
---------------------------------------------------------------------
26.02.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Alphaform AG
KapellenstraÃe 10
85622 Feldkirchen
Germany
Phone: +49 (0)89 905002 - 0
Fax: +49 (0)89 905002 - 90
E-mail: ir@alphaform.de
Internet: www.alphaform.de
ISIN: DE0005487953
WKN: 548795
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
327507 26.02.2015
DGAP-News: Alphaform AG: Preliminary figures 2014 - Alphaform targets double-digit revenue growth in 2015
| Source: EQS Group AG